Search
Now showing items 1-10 of 14
Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations
(Springer Nature, 2022)
WHO promotes the use of research in policy-making to drive improvements in health, including in achieving Sustainable Development Goals such as tobacco control. The European Union’s new €95 billion ...
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: The Modelling Algorithm Pathways in Guidelines (MAPGuide) project
(NIHR Journals Library, 2013-12)
Background: National Institute for Health and Care Excellence (NICE) clinical guidelines (CGs) make recommendations across large, complex care pathways for broad groups of patients. They rely on ...
Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania
(World Health Organization (WHO), 2009-02)
Objective To estimate the cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) using sulfadoxine-pyrimethamine (SP).
Methods In two previous IPTi trials in Ifakara (United ...
Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial
(BMC, 2011-10-19)
Background: A high percentage of cervical cancer cases have not undergone cytological tests within 10 years
prior to diagnosis. Different population interventions could improve coverage in the public ...
Cuestiones controvertidas en evaluación económica (II): medidas de resultado en salud de las intervenciones sanitarias
(Ministerio de Sanidad y Consumo, 2015-03)
En este segundo artículo, de una serie de tres, debatiremos, empleando la técnica Metaplan, sobre cuestiones controvertidas de las medidas de resultado en salud en la evaluación económica de intervenciones ...
Cuestiones controvertidas en evaluación económica (III). Intervenciones sanitarias en tres situaciones especiales: enfermedades raras, tratamientos al final de la vida y externalidades en las evaluaciones
(Ministerio de Sanidad y Consumo, 2015-05)
El desarrollo de la evaluación económica de intervenciones sanitarias se ha convertido en una herramienta de apoyo en la toma decisiones sobre financiación pública y fijación de precios de nuevas ...
How do consumers respond to “sin taxes”? New evidence from a tax on sugary drinks
(Elsevier, 2021-04)
It is unclear what the effects of taxes on sugar sweetened beverages (SSBs) are on consumer behaviour and which consumers may be affected the most. We evaluate the effect of the SSB tax introduced in ...
Herramienta de retorno de la inversión en control del tabaquismo: ¿qué opinan aquellos que toman decisiones?
(Elsevier, 2016)
Introducción: El Proyecto Europeo EQUIPT pretende adaptar una herramienta de retorno de la inversión en tabaco para varios países, con el fin de proporcionar información sobre el retorno de invertir en ...
Economic impact of HIV/AIDS: a systematic review in five European countries
(SpringerOpen, 2014-09-16)
The HIV/AIDS disease represent a priority for all health authorities in all countries and it also represents serious added socioeconomic problems for societies over the world. The aim of this paper is ...
Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study
(BMC, 2014-07-16)
Background: Cervical cancer is a frequently diagnosed cancer in women worldwide. Despite having easy
preventive and therapeutic approaches, it is an important cause of mortality among women.
Methods: ...